A US-based drug distribution company and two former executives are being prosecuted for transporting medicines to pharmacies allegedly offering opioids illegally.
Research and development in the UK will have a major boost thanks to the Medicines Discovery Catapult today launching 22 partnerships with UK-based contract research organisations (CRO
Gilead's attempts to find a treatment for nonalcoholic steatohepatitis (NASH) have been dealt another blow after another trial failure for one of its prime candidates to treat the disease.<
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
